CD44 Variant Regulates Redox Status in Cancer Cells by Stabilizing the xCT Subunit of System xc- and Thereby Promotes Tumor Growth

Cancer Cell

Volumn 19, Issue 3, 2011, Pages 387-400

  Ishimoto, Takatsugu ^a,c   Nagano, Osamu ^a,b   Yae, Toshifumi ^a   Tamada, Mayumi ^a   Motohara, Takeshi ^a   Oshima, Hiroko ^d   Oshima, Masanobu ^d   Ikeda, Tatsuya ^e   Asaba, Rika ^e   Yagi, Hideki ^e   Masuko, Takashi ^e   Shimizu, Takatsune ^a,b   Ishikawa, Tomoki ^a,f   Kai, Kazuharu ^a   Takahashi, Eri ^a   Imamura, Yu ^c   Baba, Yoshifumi ^c   Ohmura, Mitsuyo ^a   Suematsu, Makoto ^a,b   Baba, Hideo ^c   Saya, Hideyuki ^a,b   more..

^a KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

^c KUMAMOTO UNIVERSITY   (Japan)

^d KANAZAWA UNIVERSITY   (Japan)

^e KINKI UNIVERSITY   (Japan)

^f DAIICHI SANKYO CO   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CD44V ANTIGEN; CYCLIN DEPENDENT KINASE INHIBITOR 1; GLUTAMIC ACID DERIVATIVE; GLUTATHIONE; MITOGEN ACTIVATED PROTEIN KINASE P38; PROTEIN XCT; REACTIVE OXYGEN METABOLITE; UNCLASSIFIED DRUG;

ARTICLE; CANCER CELL; CELL CYCLE; CELL SURFACE; CORRELATION ANALYSIS; DIGESTIVE SYSTEM CANCER; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; HUMAN; INTESTINE CELL; MOUSE; NONHUMAN; OXIDATION REDUCTION REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; PROTEIN SYNTHESIS; REGULATORY MECHANISM; STOMACH CANCER; TUMOR GROWTH;

MUS MUSCULUS;

EID: 79952528125     PISSN: 15356108     EISSN: 18783686     Source Type: Journal    
DOI: 10.1016/j.ccr.2011.01.038     Document Type: Article

References (37)

1. Al-Hajj M., Wicha M.S., Benito-Hernandez A., Morrison S.J., Clarke M.F. Prospective identification of tumorigenic breast cancer cells. Proc. Natl. Acad. Sci. USA 2003, 100:3983-3988.
2. Behl C., Davis J.B., Lesley R., Schubert D. Hydrogen peroxide mediates amyloid beta protein toxicity. Cell 1994, 77:817-827.
3. Bulavin D.V., Phillips C., Nannenga B., Timofeev O., Donehower L.A., Anderson C.W., Appella E., Fornace A.J. Inactivation of the Wip1 phosphatase inhibits mammary tumorigenesis through p38 MAPK-mediated activation of the p16(Ink4a)-p19(Arf) pathway. Nat. Genet. 2004, 36:343-350.
4. Chen R.S., Song Y.M., Zhou Z.Y., Tong T., Li Y., Fu M., Guo X.L., Dong L.J., He X., Qiao H.X., et al. Disruption of xCT inhibits cancer cell metastasis via the caveolin-1/beta-catenin pathway. Oncogene 2009, 28:599-609.
5. Collins A.T., Berry P.A., Hyde C., Stower M.J., Maitland N.J. Prospective identification of tumorigenic prostate cancer stem cells. Cancer Res. 2005, 65:10946-10951.
6. Dalerba P., Dylla S.J., Park I.K., Liu R., Wang X., Cho R.W., Hoey T., Gurney A., Huang E.H., Simeone D.M., et al. Phenotypic characterization of human colorectal cancer stem cells. Proc. Natl. Acad. Sci. USA 2007, 104:10158-10163.
7. Diehn M., Cho R.W., Lobo N.A., Kalisky T., Dorie M.J., Kulp A.N., Qian D., Lam J.S., Ailles L.E., Wong M., et al. Association of reactive oxygen species levels and radioresistance in cancer stem cells. Nature 2009, 458:780-783.
8. Dolado I., Swat A., Ajenjo N., De Vita G., Cuadrado A., Nebreda A.R. p38alpha MAP kinase as a sensor of reactive oxygen species in tumorigenesis. Cancer Cell 2007, 11:191-205.
9. Dougherty G.J., Landorp P.M., Cooper D.L., Humphries R.K. Molecular cloning of CD44R1 and CD44R2, two novel isoforms of the human CD44 lymphocyte " homing" receptor expressed by hemopoietic cells. J. Exp. Med. 1991, 174:1-5.
10. Gout P.W., Buckley A.R., Simms C.R., Bruchovsky N. Sulfasalazine, a potent suppressor of lymphoma growth by inhibition of the x(c)- cystine transporter: a new action for an old drug. Leukemia 2001, 15:1633-1640.
11. Gunthert U., Hofmann M., Rudy W., Reber S., Zoller M., Haussmann I., Matzku S., Wenzel A., Ponta H., Herrlich P. A new variant of glycoprotein CD44 confers metastatic potential to rat carcinoma cells. Cell 1991, 65:13-24.
12. Han J., Sun P. The pathways to tumor suppression via route p38. Trends Biochem. Sci. 2007, 32:364-371.
13. Hayer S., Steiner G., Gortz B., Reiter E., Tohidast-Akrad M., Amling M., Hoffmann O., Redlich K., Zwerina J., Skriner K., et al. CD44 is a determinant of inflammatory bone loss. J. Exp. Med. 2005, 201:903-914.
14. Huang Y., Dai Z., Barbacioru C., Sadee W. Cystine-glutamate transporter SLC7A11 in cancer chemosensitivity and chemoresistance. Cancer Res. 2005, 65:7446-7454.
15. Ishii T., Sugita Y., Bannai S. Regulation of glutathione levels in mouse spleen lymphocytes by transport of cysteine. J. Cell. Physiol. 1987, 133:330-336.
16. Ishimoto T., Oshima H., Oshima M., Kai K., Torii R., Masuko T., Baba H., Saya H., Nagano O. CD44(+) slow-cycling tumor cell expansion is triggered by cooperative actions of Wnt and prostaglandin E(2) in gastric tumorigenesis. Cancer Sci. 2010, 101:673-678.
17. Ito K., Hirao A., Arai F., Takubo K., Matsuoka S., Miyamoto K., Ohmura M., Naka K., Hosokawa K., Ikeda Y., Suda T. Reactive oxygen species act through p38 MAPK to limit the lifespan of hematopoietic stem cells. Nat. Med. 2006, 12:446-451.
18. Katz J.P., Perreault N., Goldstein B.G., Actman L., McNally S.R., Silberg D.G., Furth E.E., Kaestner K.H. Loss of Klf4 in mice causes altered proliferation and differentiation and precancerous changes in the adult stomach. Gastroenterology 2005, 128:935-945.
19. Lo M., Wang Y.Z., Gout P.W. The x(c)- cystine/glutamate antiporter: a potential target for therapy of cancer and other diseases. J. Cell. Physiol. 2008, 215:593-602.
20. Muller M. Cellular senescence: molecular mechanisms, in vivo significance, and redox considerations. Antioxid. Redox Signal. 2009, 11:59-98.
21. Nagano O., Saya H. Mechanism and biological significance of CD44 cleavage. Cancer Sci. 2004, 95:930-935.
22. Nagano O., Murakami D., Hartmann D., De Strooper B., Saftig P., Iwatsubo T., Nakajima M., Shinohara M., Saya H. Cell-matrix interaction via CD44 is independently regulated by different metalloproteinases activated in response to extracellular Ca(2+) influx and PKC activation. J. Cell Biol. 2004, 165:893-902.
23. Oshima H., Matsunaga A., Fujimura T., Tsukamoto T., Taketo M.M., Oshima M. Carcinogenesis in mouse stomach by simultaneous activation of the Wnt signaling and prostaglandin E2 pathway. Gastroenterology 2006, 131:1086-1095.
24. Owusu-Ansah E., Banerjee U. Reactive oxygen species prime Drosophila haematopoietic progenitors for differentiation. Nature 2009, 461:537-541.
25. Phillips T.M., McBride W.H., Pajonk F. The response of CD24(-/low)/CD44+ breast cancer-initiating cells to radiation. J. Natl. Cancer Inst. 2006, 98:1777-1785.
26. Ponta H., Sherman L., Herrlich P.A. CD44: from adhesion molecules to signalling regulators. Nat. Rev. Mol. Cell Biol. 2003, 4:33-45.
27. Sasaki H., Sato H., Kuriyama-Matsumura K., Sato K., Maebara K., Wang H., Tamba M., Itoh K., Yamamoto M., Bannai S. Electrophile response element-mediated induction of the cystine/glutamate exchange transporter gene expression. J. Biol. Chem. 2002, 277:44765-44771.
28. Sato H., Shiiya A., Kimata M., Maebara K., Tamba M., Sakakura Y., Makino N., Sugiyama F., Yagami K., Moriguchi T., et al. Redox imbalance in cystine/glutamate transporter-deficient mice. J. Biol. Chem. 2005, 280:37423-37429.
29. Schmits R., Filmus J., Gerwin N., Senaldi G., Kiefer F., Kundig T., Wakeham A., Shahinian A., Catzavelos C., Rak J., et al. CD44 regulates hematopoietic progenitor distribution, granuloma formation, and tumorigenicity. Blood 1997, 90:2217-2233.
30. Shintani T., Iwabuchi T., Soga T., Kato Y., Yamamoto T., Takano N., Hishiki T., Ueno Y., Ikeda S., Sakuragawa T., et al. Cystathionine beta-synthase as a carbon monoxide-sensitive regulator of bile excretion. Hepatology 2009, 49:141-150.
31. Slomiany M.G., Grass G.D., Robertson A.D., Yang X.Y., Maria B.L., Beeson C., Toole B.P. Hyaluronan, CD44, and emmprin regulate lactate efflux and membrane localization of monocarboxylate transporters in human breast carcinoma cells. Cancer Res. 2009, 69:1293-1301.
32. Suematsu M., Suzuki H., Ishii H., Kato S., Yanagisawa T., Asako H., Suzuki M., Tsuchiya M. Early midzonal oxidative stress preceding cell death in hypoperfused rat liver. Gastroenterology 1992, 103:994-1001.
33. Tanabe K.K., Ellis L.M., Saya H. Expression of CD44R1 adhesion molecule in colon carcinomas and metastases. Lancet 1993, 341:725-726.
34. Trachootham D., Alexandre J., Huang P. Targeting cancer cells by ROS-mediated mechanisms: a radical therapeutic approach?. Nat. Rev. Drug Discov. 2009, 8:579-591.
35. van de Wetering M., Sancho E., Verweij C., de Lau W., Oving I., Hurlstone A., van der Horn K., Batlle E., Coudreuse D., Haramis A.P., et al. The beta-catenin/TCF-4 complex imposes a crypt progenitor phenotype on colorectal cancer cells. Cell 2002, 111:241-250.
36. Vermeulen L., De Sousa E.M.F., van der Heijden M., Cameron K., de Jong J.H., Borovski T., Tuynman J.B., Todaro M., Merz C., Rodermond H., et al. Wnt activity defines colon cancer stem cells and is regulated by the microenvironment. Nat. Cell Biol. 2010, 12:468-476.
37. Verrey F., Closs E.I., Wagner C.A., Palacin M., Endou H., Kanai Y. CATs and HATs: the SLC7 family of amino acid transporters. Pflugers Arch. 2004, 447:532-542.